AI assistant
Sending…
GILEAD SCIENCES, INC. — Director's Dealing 2015
Mar 3, 2015
29828_dirs_2015-03-03_277246b5-63ee-4647-9528-39e817ee9b54.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-03-01
Reporting Person: MOORE NICHOLAS G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-01 | Common Stock | M | 167 | — | Acquired | 15119 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-01 | Phantom Stock | $ | M | 167 | Disposed | Common Stock (167) | Direct |
Footnotes
F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.
F2: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.
F3: An aggregate of 167.168 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.168 was paid out in cash in connection with the conversion into shares of common stock.
More from GILEAD SCIENCES, INC.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30